Cargando…

Protein markers of cancer-associated fibroblasts and tumor-initiating cells reveal subpopulations in freshly isolated ovarian cancer ascites

BACKGROUND: In ovarian cancer, massive intraperitoneal dissemination is due to exfoliated tumor cells in ascites. Tumor-initiating cells (TICs or cancer stem cells) and cells showing epithelial-mesenchymal-transition (EMT) are particularly implicated. Spontaneous spherical cell aggregates are someti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wintzell, My, Hjerpe, Elisabet, Åvall Lundqvist, Elisabeth, Shoshan, Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3517779/ https://www.ncbi.nlm.nih.gov/pubmed/22901285 http://dx.doi.org/10.1186/1471-2407-12-359

Ejemplares similares

Metabolic markers GAPDH, PKM2, ATP5B and BEC-index in advanced serous ovarian cancer
por: Hjerpe, Elisabet, et al.
Publicado: (2013)

Markers of fibroblast-rich tumor stroma and perivascular cells in serous ovarian cancer: Inter- and intra-patient heterogeneity and impact on survival
por: Corvigno, Sara, et al.
Publicado: (2016)

Chemotherapy vs tamoxifen in platinum-resistant ovarian cancer: a phase III, randomised, multicentre trial (Ovaresist)
por: Lindemann, Kristina, et al.
Publicado: (2017)

Survival in endometrial cancer in relation to minimally invasive surgery or open surgery – a Swedish Gynecologic Cancer Group (SweGCG) study
por: Borgfeldt, Christer, et al.
Publicado: (2021)

Tumor cell-fibroblast heterotypic aggregates in malignant ascites of patients with ovarian cancer
por: Han, Qing, et al.
Publicado: (2019)

Malignant Ascites Promote Adhesion of Ovarian Cancer Cells to Peritoneal Mesothelium and Fibroblasts
por: Uruski, Paweł, et al.
Publicado: (2021)

Modulation of Immune Infiltration of Ovarian Cancer Tumor Microenvironment by Specific Subpopulations of Fibroblasts
por: Wang, Ji, et al.
Publicado: (2020)

Comparative study of various subpopulations of cytotoxic cells in blood and ascites from patients with ovarian carcinoma
por: Lukesova, Sarka, et al.
Publicado: (2015)

The Angiogenic Activity of Ascites in the Course of Ovarian Cancer as a Marker of Disease Progression
por: Gawrychowski, Krzysztof, et al.
Publicado: (2014)

Ascitic complement system in ovarian cancer
por: Bjørge, L, et al.
Publicado: (2005)

The bright side of ascites in ovarian cancer
por: Cohen, Marie, et al.
Publicado: (2014)

Ascites Volumes and the Ovarian Cancer Microenvironment
por: Penet, Marie-France, et al.
Publicado: (2018)

Deciphering the ovarian cancer ascites fluid peptidome
por: Bery, Anand, et al.
Publicado: (2014)

Chlamydia Peritonitis and Ascites Mimicking Ovarian Cancer
por: Gojayev, Anar, et al.
Publicado: (2016)

Immune Tumor Microenvironment in Ovarian Cancer Ascites
por: Almeida-Nunes, Diana Luísa, et al.
Publicado: (2022)

The Epithelial-Mesenchymal Transition Initiated by Malignant Ascites Underlies the Transmesothelial Invasion of Ovarian Cancer Cells
por: Pakuła, Martyna, et al.
Publicado: (2019)

An apoptosis-enhancing drug overcomes platinum resistance in a tumour-initiating subpopulation of ovarian cancer
por: Janzen, D. M., et al.
Publicado: (2015)

Deciphering the temporal heterogeneity of cancer-associated fibroblast subpopulations in breast cancer
por: Venning, Freja Albjerg, et al.
Publicado: (2021)

Expression of Mitochondrial Regulators PGC1α and TFAM as Putative Markers of Subtype and Chemoresistance in Epithelial Ovarian Carcinoma
por: Gabrielson, Marike, et al.
Publicado: (2014)

Typing of pancreatic cancer-associated fibroblasts identifies different subpopulations
por: Nielsen, Michael Friberg Bruun, et al.
Publicado: (2018)

Identification and Characterization of Cancer-Associated Fibroblast Subpopulations in Lung Adenocarcinoma
por: Kim, Daeseung, et al.
Publicado: (2022)

Mirk kinase inhibition targets ovarian cancer ascites
por: Deng, Xiaobing, et al.
Publicado: (2014)

The untapped potential of ascites in ovarian cancer research and treatment
por: Ford, Caroline Elizabeth, et al.
Publicado: (2020)

Oncolytic adenovirus inhibits malignant ascites of advanced ovarian cancer by reprogramming the ascitic immune microenvironment
por: Shi, Gang, et al.
Publicado: (2021)

Impact of persistent peripheral neuropathy on health-related quality of life among early-stage breast cancer survivors: a population-based cross-sectional study
por: Engvall, Kristina, et al.
Publicado: (2022)

Real World Evidence on Second-Line Palliative Chemotherapy in Advanced Pancreatic Cancer
por: Gränsmark, Emma, et al.
Publicado: (2020)

Corrigendum: An apoptosis-enhancing drug overcomes platinum resistance in a tumour-initiating subpopulation of ovarian cancer
por: Janzen, D. M., et al.
Publicado: (2016)

Chemotherapy sensitivity testing on ovarian cancer cells isolated from malignant ascites
por: den Ouden, Judith E., et al.
Publicado: (2020)

Identification of Specific Cell Subpopulations and Marker Genes in Ovarian Cancer Using Single-Cell RNA Sequencing
por: Li, Yan, et al.
Publicado: (2021)

Cancer-Associated Fibroblast Subpopulations With Diverse and Dynamic Roles in the Tumor Microenvironment
por: Simon, Thomas, et al.
Publicado: (2022)

Retraction Note: An apoptosis-enhancing drug overcomes platinum resistance in a tumour-initiating subpopulation of ovarian cancer
por: Janzen, D. M., et al.
Publicado: (2020)

Microheterogeneity of transthyretin in serum and ascitic fluid of ovarian cancer patients
por: Gericke, Beate, et al.
Publicado: (2005)

Metabolic factors contribute to T‐cell inhibition in the ovarian cancer ascites
por: Gong, Yueqing, et al.
Publicado: (2020)

Characteristics of Selected Adipokines in Ascites and Blood of Ovarian Cancer Patients
por: Wróblewski, Marcin, et al.
Publicado: (2021)

Isolation and Characterization of Tumor Cells from the Ascites of Ovarian Cancer Patients: Molecular Phenotype of Chemoresistant Ovarian Tumors
por: Latifi, Ardian, et al.
Publicado: (2012)

Ascites modulates cancer cell behavior, contributing to tumor heterogeneity in ovarian cancer
por: Kim, Soochi, et al.
Publicado: (2016)

Real-world evaluation of upfront docetaxel in metastatic castration-sensitive prostate cancer
por: Isaksson, Jenny, et al.
Publicado: (2021)

The heterogeneity of cancer‐associated fibroblast subpopulations: Their origins, biomarkers, and roles in the tumor microenvironment
por: Yamamoto, Yurie, et al.
Publicado: (2022)

Role of cancer‐associated fibroblast subpopulations in immune infiltration, as a new means of treatment in cancer
por: Mhaidly, Rana, et al.
Publicado: (2021)

Emerging treatment options for management of malignant ascites in patients with ovarian cancer
por: Eskander, Ramez N, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_o17mdi55ramr38hr3jf0b53ah9